Literature DB >> 25361894

Cables1 complex couples survival signaling to the cell death machinery.

Zhi Shi1,2, Hae Ryon Park2,3, Yuhong Du2,4, Zijian Li2,5, Kejun Cheng2,6, Shi-Yong Sun7, Zenggang Li2, Haian Fu2,7,4, Fadlo R Khuri7,4.   

Abstract

Cables1 is a candidate tumor suppressor that negatively regulates cell growth by inhibiting cyclin-dependent kinases. Cables1 expression is lost frequently in human cancer but little is known about its regulation. Here, we report that Cables1 levels are controlled by a phosphorylation and 14-3-3-dependent mechanism. Mutagenic analyses identified two residues, T44 and T150, that are specifically critical for 14-3-3 binding and that serve as substrates for phosphorylation by the cell survival kinase Akt, which by binding directly to Cables1 recruits 14-3-3 to the complex. In cells, Cables1 overexpression induced apoptosis and inhibited cell growth in part by stabilizing p21 and decreasing Cdk2 kinase activity. Ectopic expression of activated Akt (AKT1) prevented Cables1-induced apoptosis. Clinically, levels of phosphorylated Cables1 and phosphorylated Akt correlated with each other in human lung cancer specimens, consistent with pathophysiologic significance. Together, our results illuminated a dynamic regulatory system through which activated Akt and 14-3-3 work directly together to neutralize a potent tumor suppressor function of Cables1. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25361894      PMCID: PMC4617824          DOI: 10.1158/0008-5472.CAN-14-0036

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

2.  C-terminal recognition by 14-3-3 proteins for surface expression of membrane receptors.

Authors:  Brian Coblitz; Sojin Shikano; Meng Wu; Sandra B Gabelli; Lisa M Cockrell; Matt Spieker; Yoshiro Hanyu; Haian Fu; L Mario Amzel; Min Li
Journal:  J Biol Chem       Date:  2005-08-24       Impact factor: 5.157

3.  Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition.

Authors:  Kazuhiro Katayama; Naoya Fujita; Takashi Tsuruo
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  The structural basis for 14-3-3:phosphopeptide binding specificity.

Authors:  M B Yaffe; K Rittinger; S Volinia; P R Caron; A Aitken; H Leffers; S J Gamblin; S J Smerdon; L C Cantley
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

5.  Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

Authors:  S R Datta; H Dudek; X Tao; S Masters; H Fu; Y Gotoh; M E Greenberg
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

6.  Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

Authors:  J Zha; H Harada; E Yang; J Jockel; S J Korsmeyer
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

7.  Increased growth rate, delayed senescense and decreased serum dependence characterize cables-deficient cells.

Authors:  Sandra D Kirley; Bo R Rueda; Daniel C Chung; Lawrence R Zukerberg
Journal:  Cancer Biol Ther       Date:  2005-06-11       Impact factor: 4.742

8.  Activation of apoptosis signal-regulating kinase 1 by reactive oxygen species through dephosphorylation at serine 967 and 14-3-3 dissociation.

Authors:  Erinn H Goldman; Lei Chen; Haian Fu
Journal:  J Biol Chem       Date:  2003-12-19       Impact factor: 5.157

9.  Negative control of apoptosis signal-regulating kinase 1 through phosphorylation of Ser-1034.

Authors:  Katsunori Fujii; Erinn Hoag Goldman; Hae Ryoun Park; Lixin Zhang; Jing Chen; Haian Fu
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

10.  14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.

Authors:  Mercedes Pozuelo Rubio; Kathryn M Geraghty; Barry H C Wong; Nicola T Wood; David G Campbell; Nick Morrice; Carol Mackintosh
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

View more
  23 in total

1.  ODAM is a predictor for biomedical recurrence and inhibits the migration and invasion of prostate cancer.

Authors:  Yun Luo; Jie-Ying Wu; Guo-Liang Hou; Min-Hua Lu; Zhi Shi; Jin-Ming Di
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.

Authors:  Zachary R Hunter; Lian Xu; Guang Yang; Nicholas Tsakmaklis; Josephine M Vos; Xia Liu; Jie Chen; Robert J Manning; Jiaji G Chen; Philip Brodsky; Christopher J Patterson; Joshua Gustine; Toni Dubeau; Jorge J Castillo; Kenneth C Anderson; Nikhil M Munshi; Steven P Treon
Journal:  Blood       Date:  2016-06-14       Impact factor: 22.113

3.  Volasertib suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.

Authors:  Di-Wei Zheng; You-Qiu Xue; Yong Li; Jin-Ming Di; Jian-Ge Qiu; Wen-Ji Zhang; Qi-Wei Jiang; Yang Yang; Yao Chen; Meng-Ning Wei; Jia-Rong Huang; Kun Wang; Xing Wei; Zhi Shi
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

4.  Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer.

Authors:  Xiao-Xiu Huang; Feng-Feng Xie; Li-Jiao Hou; Xiu-Xiu Chen; Rong-Ying Ou; Jiang-Tao Yu; Jian-Ge Qiu; Wen-Ji Zhang; Qi-Wei Jiang; Yang Yang; Di-Wei Zheng; Yao Chen; Jia-Rong Huang; Kun Wang; Meng-Ning Wei; Wen-Feng Li; Zhi Shi; Xiao-Jian Yan
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

5.  Caragaphenol a induces reactive oxygen species related apoptosis in human gastric cancer cells.

Authors:  Qi-Qi Peng; Kun Wang; Ke-Jun Cheng; Hai-Gan Yang; Jian-Ge Qiu; Wen-Ji Zhang; Qi-Wei Jiang; Yang Yang; Di-Wei Zheng; Jia-Rong Huang; Meng-Ning Wei; Zhi Shi; Wei Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 6.  Genetics of Cushing's Syndrome.

Authors:  Laura C Hernández-Ramírez; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

7.  Wallichinine reverses ABCB1-mediated cancer multidrug resistance.

Authors:  Min Lv; Jian-Ge Qiu; Wen-Ji Zhang; Qi-Wei Jiang; Wu-Ming Qin; Yang Yang; Di-Wei Zheng; Yao Chen; Jia-Rong Huang; Kun Wang; Meng-Ning Wei; Ke-Jun Cheng; Zhi Shi
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

8.  Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo.

Authors:  Xiao-Long Mei; Yang Yang; Yao-Jun Zhang; Yong Li; Jin-Ming Zhao; Jian-Ge Qiu; Wen-Ji Zhang; Qi-Wei Jiang; You-Qiu Xue; Di-Wei Zheng; Yao Chen; Wu-Ming Qin; Meng-Ning Wei; Zhi Shi
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

9.  Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer.

Authors:  Feng-Feng Xie; Shi-Shi Pan; Rong-Ying Ou; Zhen-Zhen Zheng; Xiao-Xiu Huang; Meng-Ting Jian; Jian-Ge Qiu; Wen-Ji Zhang; Qi-Wei Jiang; Yang Yang; Wen-Feng Li; Zhi Shi; Xiao-Jian Yan
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

10.  YM155 enhances docetaxel efficacy in ovarian cancer.

Authors:  Li-Jiao Hou; Xiao-Xiu Huang; Li-Na Xu; Yan-Yan Zhang; Na Zhao; Rong-Ying Ou; Wen-Feng Li; Wen-Ji Zhang; Qi-Wei Jiang; Yang Yang; Meng-Ning Wei; Jia-Rong Huang; Kun Wang; Meng-Ling Yuan; Zi-Hao Xing; Zhi Shi; Xiao-Jian Yan
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.